Cancer Testing

Revised USPSTF Guidelines Tied to Increase in PSA Cancer Screening Rates

Nearly five years later, it appears that the decision of US Preventive Services Task Force (USPSTF) to reverse its recommendations that discouraged prostate cancer screening has resulted in a … [Read more...]


FDA Unveils New Process for Streamlined Review of IVD Tests Used in Cancer Drug Trials

Typically,¬†in vitro¬†diagnostic (IVDs) tests used in investigational cancer drug trials require two submissions: one for the IVD test and another for the drug. But on Oct. 9, 2019, the US Food and Drug … [Read more...]


Testing Trends: The Debate Continues Over Regular Colorectal Screening for Average Risk Adults

Should adults age 50 to 75 who are at average risk and show no symptoms of colorectal cancer have regular colorectal screening exams? Last month, a major medical journal came out against regular … [Read more...]


Emerging Tests: New Genetic Tests May Be Better than PSA Screening in Assessing Prostate Cancer Risk

The U.S. Preventive Services Task Force (USPTF) recommends that men age 55 to 65 consider prostate cancer screening based on their specific circumstances. The reason that the USPTF does not directly … [Read more...]